Radiation Therapy and Docetaxel in Treating Patients With HPV-Related Oropharyngeal Cancer
Status:
Active, not recruiting
Trial end date:
2020-12-30
Target enrollment:
Participant gender:
Summary
This phase II trial studies how well radiation therapy and docetaxel work in treating
patients with human papillomavirus (HPV)-related oropharyngeal cancer. Radiation therapy uses
high-energy x-rays to kill tumor cells. Drugs used in chemotherapy, such as docetaxel, work
in different ways to stop the growth of tumor cells, either by killing the cells, by stopping
them from dividing, or by stopping them from spreading. Giving radiation therapy with
docetaxel my kill more tumor cells.